165 related articles for article (PubMed ID: 17377812)
1. Cytological diagnosis of malignant mesothelioma--improvement by additional analysis of hyaluronic acid in pleural effusions.
Welker L; Müller M; Holz O; Vollmer E; Magnussen H; Jörres RA
Virchows Arch; 2007 Apr; 450(4):455-61. PubMed ID: 17377812
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid content of effusions as a diagnostic aid for malignant mesothelioma.
Roboz J; Greaves J; Silides D; Chahinian AP; Holland JF
Cancer Res; 1985 Apr; 45(4):1850-4. PubMed ID: 3978644
[TBL] [Abstract][Full Text] [Related]
3. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
4. Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma.
Creaney J; Dick IM; Segal A; Musk AW; Robinson BW
Lung Cancer; 2013 Dec; 82(3):491-8. PubMed ID: 24161718
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma.
Fujimoto N; Gemba K; Asano M; Fuchimoto Y; Wada S; Ono K; Ozaki S; Kishimoto T
Respir Investig; 2013 Jun; 51(2):92-7. PubMed ID: 23790737
[TBL] [Abstract][Full Text] [Related]
7. Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma.
Pettersson T; Fröseth B; Riska H; Klockars M
Chest; 1988 Nov; 94(5):1037-9. PubMed ID: 3180855
[TBL] [Abstract][Full Text] [Related]
8. Thoracoscopy in the diagnosis of malignant mesothelioma.
Martensson G
Poumon Coeur; 1981; 37(4):249-51. PubMed ID: 7312754
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology.
Canessa PA; Franceschini MC; Ferro P; Battolla E; Dessanti P; Manta C; Sivori M; Pezzi R; Fontana V; Fedeli F; Pistillo MP; Roncella S
Cancer Invest; 2013 Jan; 31(1):43-50. PubMed ID: 23249166
[TBL] [Abstract][Full Text] [Related]
10. [Mesothelioma of the pleura: cytology, coagulation of protein (Weltmann) and hyaluronic acid as parameters of clinical diagnosis (author's transl)].
Matzel W
Z Erkr Atmungsorgane; 1980; 155(1):133-9. PubMed ID: 7210738
[TBL] [Abstract][Full Text] [Related]
11. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
Rakha EA; Patil S; Abdulla K; Abdulkader M; Chaudry Z; Soomro IN
Diagn Cytopathol; 2010 Dec; 38(12):874-9. PubMed ID: 20049969
[TBL] [Abstract][Full Text] [Related]
12. Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.
Beije N; Kraan J; den Bakker MA; Maat APWM; van der Leest C; Cornelissen R; Van NM; Martens JWM; Aerts JGJV; Sleijfer S
Cell Oncol (Dordr); 2017 Oct; 40(5):511-519. PubMed ID: 28577209
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan in pleural effusions and in serum.
Hillerdal G; Lindqvist U; Engström-Laurent A
Cancer; 1991 May; 67(9):2410-4. PubMed ID: 2013045
[TBL] [Abstract][Full Text] [Related]
14. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.
Rossi ED; Bizzarro T; Schmitt F; Longatto-Filho A
Cancer Cytopathol; 2015 Apr; 123(4):258-66. PubMed ID: 25641902
[TBL] [Abstract][Full Text] [Related]
15. The role of cytological evaluation of pleural fluid in diagnosing malignant mesothelioma.
Lovrenski A; Panjković M; Tegeltija D; Latinović LT; Krcedinac J
Med Pregl; 2012; 65(1-2):5-8. PubMed ID: 22452231
[TBL] [Abstract][Full Text] [Related]
16. A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit.
Segal A; Sterrett GF; Frost FA; Shilkin KB; Olsen NJ; Musk AW; Nowak AK; Robinson BW; Creaney J
Pathology; 2013 Jan; 45(1):44-8. PubMed ID: 23222247
[TBL] [Abstract][Full Text] [Related]
17. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
Afify A; Lynne LC; Howell L
Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
[TBL] [Abstract][Full Text] [Related]
18. Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma.
Atagi S; Ogawara M; Kawahara M; Sakatani M; Furuse K; Ueda E; Yamamoto S
Jpn J Clin Oncol; 1997 Oct; 27(5):293-7. PubMed ID: 9390204
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of mesothelin in pleural effusions versus histology by medical thoracoscopy: brief report.
Canessa PA; Ferro P; Manta C; Sivori M; Franceschini MC; Fedeli F; Roncella S
Med Oncol; 2013; 30(3):649. PubMed ID: 23873013
[TBL] [Abstract][Full Text] [Related]
20. Cytological Diagnostic Procedures in Malignant Mesothelioma.
Biancosino C; van der Linde LIS; Sauter G; Stellmacher F; Krüger M; Welker L
Adv Exp Med Biol; 2022; 1374():41-49. PubMed ID: 34787829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]